Literature DB >> 15294958

CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12.

Anton V Gorbachev1, Robert L Fairchild.   

Abstract

The delivery of CD40 signaling to APCs during T cell priming enhances many T cell-mediated immune responses. Although CD40 signaling up-regulates APC production of IL-12, the impact of this increased production on T cell priming is unclear. In this study an IL-12-independent T cell-mediated immune response, contact hypersensitivity (CHS), was used to further investigate the effect of CD40 ligation on the phenotypic development of Ag-specific CD4(+) and CD8(+) T cells. Normally, sensitization for CHS responses induces hapten-specific CD4(+) T cells producing type 2 cytokines and CD8(+) T cells producing IFN-gamma. Treatment of mice with agonist anti-CD40 mAb during sensitization with the hapten 2,4-dinitrofluorobenzene resulted in CHS responses of increased magnitude and duration. These augmented responses in anti-CD40 Ab-treated mice correlated with increased numbers of hapten-specific CD4(+) and CD8(+) T cells producing IFN-gamma in the skin draining lymph nodes. Identical results were observed using IL-12(-/-) mice, indicating that CD40 ligation promotes CHS responses and development of IFN-gamma-producing CD4(+) and CD8(+) T cells in the absence of IL-12. Engagement of CD40 on hapten-presenting Langerhans cells (hpLC) up-regulated the expression of both class I and class II MHC and promoted hpLC migration into the T cell priming site. These results indicate that hpLC stimulated by CD40 ligation use a mechanism distinct from increased IL-12 production to promote Ag-specific T cell development to IFN-gamma-producing cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294958     DOI: 10.4049/jimmunol.173.4.2443

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Inflammatory spleen monocytes can upregulate CD11c expression without converting into dendritic cells.

Authors:  Scott B Drutman; Julia C Kendall; E Sergio Trombetta
Journal:  J Immunol       Date:  2012-03-21       Impact factor: 5.422

2.  DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance.

Authors:  Patricia Conde; Mercedes Rodriguez; William van der Touw; Ana Jimenez; Matthew Burns; Jennifer Miller; Manisha Brahmachary; Hui-ming Chen; Peter Boros; Francisco Rausell-Palamos; Tae Jin Yun; Paloma Riquelme; Alberto Rastrojo; Begoña Aguado; Joan Stein-Streilein; Masato Tanaka; Lan Zhou; Junfeng Zhang; Todd L Lowary; Florent Ginhoux; Chae Gyu Park; Cheolho Cheong; Joshua Brody; Shannon J Turley; Sergio A Lira; Vincenzo Bronte; Siamon Gordon; Peter S Heeger; Miriam Merad; James Hutchinson; Shu-Hsia Chen; Jordi Ochando
Journal:  Immunity       Date:  2015-06-09       Impact factor: 31.745

3.  CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors.

Authors:  Joshua M Rosenblum; Naohiko Shimoda; Austin D Schenk; Howard Zhang; Danielle D Kish; Karen Keslar; Joshua M Farber; Robert L Fairchild
Journal:  J Immunol       Date:  2010-03-01       Impact factor: 5.422

Review 4.  Glomerulonephritis, Th1 and Th2: what's new?

Authors:  P G Tipping; A R Kitching
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

5.  Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function.

Authors:  Shalini Gupta; Ramanamurthy Boppana; Gyan C Mishra; Bhaskar Saha; Debashis Mitra
Journal:  Immunology       Date:  2008-02-20       Impact factor: 7.397

6.  In the absence of CD154, administration of interleukin-12 restores Th1 responses but not protective immunity to Schistosoma mansoni.

Authors:  James P Hewitson; Paul A Hamblin; Adrian P Mountford
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

7.  Epidermal Langerhans cells promote skin allograft rejection in mice with NF-kappa B-impaired T cells.

Authors:  L L Molinero; P Zhou; Y Wang; H Harlin; B Kee; C Abraham; M L Alegre
Journal:  Am J Transplant       Date:  2007-11-16       Impact factor: 8.086

8.  Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity.

Authors:  Stefan F Martin; Jan C Dudda; Eva Bachtanian; Annalisa Lembo; Stefanie Liller; Christoph Dürr; Markus M Heimesaat; Stefan Bereswill; György Fejer; Ralitsa Vassileva; Thilo Jakob; Nikolaus Freudenberg; Christian C Termeer; Caroline Johner; Chris Galanos; Marina A Freudenberg
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307

9.  The roles of IL-17C in T cell-dependent and -independent inflammatory diseases.

Authors:  Sachiko Yamaguchi; Aya Nambu; Takafumi Numata; Takamichi Yoshizaki; Seiko Narushima; Eri Shimura; Yoshihisa Hiraishi; Ken Arae; Hideaki Morita; Kenji Matsumoto; Ichiro Hisatome; Katsuko Sudo; Susumu Nakae
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.